In this study, we have found that CDK5 knockdown inhibits phosphorylation of AKT, and induces G1 cell cycle arrest, apoptosis and enhanced sensitivity to paclitaxel in ovarian cancer cell lines. Here, CDK5 is linked to ovarian cancer.